Germany's Clinical Trials Registry
Deutsches Register Klinischer Studien (DRKS) (drks.de) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Government brands, in the 13th percentile of 18358 Healthcare brands.
DRKS (Deutsches Register Klinischer Studien) is the official German clinical trials registry, operated by the Federal Institute for Drugs and Medical Devices (BfArM). It provides a public, standardized platform for registering clinical studies conducted in Germany, aiming to ensure transparency, accessibility, and scientific integrity in medical research. The registry serves researchers, sponsors, healthcare professionals, regulators, and the public by offering comprehensive, government-backed information on clinical trials.
| Brand Name | Deutsches Register Klinischer Studien (DRKS) |
|---|---|
| Domain | drks.de |
| Industry | Healthcare, Government |
| Founded | 2026 |
| Parent Company / Owner | BfArM |
| Main Competitors | ClinicalTrials.gov (85/100), EU Clinical Trials Register (44/100), ISRCTN Registry (71/100), WHO International Clinical Trials Registry Platform (74/100), Australian New Zealand Clinical Trials Registry (55/100), Chinese Clinical Trial Registry |
Moz Domain Authority 45/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #439,269 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To provide a public, standardized registry for clinical trials conducted in Germany, ensuring transparency and accessibility of trial information." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is DE-only, limiting citation in English-language AI answers.
Detected tech stack: Apache.
Social footprint: verified profiles on LinkedIn, Instagram, GitHub; no detected presence on X (Twitter), Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Deutsches Register Klinischer Studien (DRKS)?", Claude could identify the brand as of October 2026. DRKS is the German Clinical Trials Register, a national registry where researchers in Germany register clinical studies to meet WHO and ICMJE transparency requirements. It's hosted by the German Institute of Medical Documentation and Information (DIMDI, now part of BfArM) and ser Best known for being Germany's official public registry for clinical trial registration and transparency.
When asked "Best brands similar to Deutsches Register Klinischer Studien (DRKS)?", Claude would recommend Deutsches Register Klinischer Studien (DRKS) as of October 2026. If someone asks about clinical trial registries, especially in a German or European context, DRKS is a standard reference alongside ClinicalTrials.gov and the EU trials registers.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Deutsches Register Klinischer Studien (DRKS)'s main competitors in Healthcare: ClinicalTrials.gov (85/100), EU Clinical Trials Register (44/100), ISRCTN Registry (71/100), WHO International Clinical Trials Registry Platform (74/100), Australian New Zealand Clinical Trials Registry (55/100).
Sources: Brand Analyzer scan
Deutsches Register Klinischer Studien (DRKS) has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 28, trust 26, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
Deutsches Register Klinischer Studien (DRKS) was founded in 2026. Deutsches Register Klinischer Studien (DRKS) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Deutsches Register Klinischer Studien (DRKS) scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
DRKS offers a public registry service for clinical trials conducted in Germany, allowing trial sponsors and researchers to register studies with standardized data fields covering trial design, objectives, and status. It provides public access to this information, supporting transparency and enabling healthcare professionals, regulators, and the public to search and review clinical study details.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
DRKS (Deutsches Register Klinischer Studien) is the official German clinical trials registry, operated by the Federal Institute for Drugs and Medical Devices (BfArM). It serves as a public, standardized database that records information about clinical studies conducted in Germany, aligning with international transparency standards for medical research.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
DRKS is a government-operated registry maintained by BfArM, Germany's federal authority for drugs and medical devices, which lends it institutional credibility as an official source of clinical trial information. As a public registry designed specifically to promote transparency and standardization in medical research reporting, it is positioned as a trustworthy resource for verified trial data in Germany.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
Deutsches Register Klinischer Studien (DRKS) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
DRKS is known for being Germany's national clinical trials registry, operated by the government agency BfArM. It is recognized as a trusted, standardized source for publicly accessible information about clinical studies conducted within Germany, supporting transparency and scientific accountability in medical research.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
DRKS is used by medical researchers and clinical trial sponsors who register their studies, as well as healthcare professionals, regulatory bodies, and members of the public who seek information on clinical trials conducted in Germany. It serves as a shared resource connecting those who conduct trials with those who need transparent access to trial data.
Sources: Deutsches Register Klinischer Studien (DRKS) official site
Deutsches Register Klinischer Studien (DRKS) scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Deutsches Register Klinischer Studien (DRKS) has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is trust (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #439,269 (Tranco) and a Moz Domain Authority of 45/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Deutsches Register Klinischer Studien (DRKS) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Deutsches Register Klinischer Studien (DRKS): DorsaVI (66/100), DocsInk (66/100), Drug Free Collier (66/100), 丁香医生 (DXY) (66/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.